2012
DOI: 10.1155/2012/934707
|View full text |Cite
|
Sign up to set email alerts
|

Nuclear Receptor Variants in Liver Disease

Abstract: This review aims to provide a snapshot of the actual state of knowledge on genetic variants of nuclear receptors (NR) involved in regulating important aspects of liver metabolism. It recapitulates recent evidence for the application of NR in genetic diagnosis of monogenic (“Mendelian”) liver disease and their use in clinical diagnosis. Genetic analysis of multifactorial liver diseases such as viral hepatitis or fatty liver disease identifies key players in disease predisposition and progression. Eviden… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 87 publications
0
4
0
Order By: Relevance
“…We did also not detect any expression difference for the transcription factor Srebf1 , which activates the expression of genes dedicated to sterol, triglyceride, and PC synthesis (40) and is repressed by PC (13), between Abcb4 –/– and wild‐type mice in vivo. In contrast, the expression of Ppargc1a and the transcription factor Foxo1 , both involved in the regulation of gluconeogenesis (41), is induced.…”
Section: Resultsmentioning
confidence: 99%
“…We did also not detect any expression difference for the transcription factor Srebf1 , which activates the expression of genes dedicated to sterol, triglyceride, and PC synthesis (40) and is repressed by PC (13), between Abcb4 –/– and wild‐type mice in vivo. In contrast, the expression of Ppargc1a and the transcription factor Foxo1 , both involved in the regulation of gluconeogenesis (41), is induced.…”
Section: Resultsmentioning
confidence: 99%
“… 59 Secondly, FXR promotes fatty acid consumption by activating fatty acid β-oxidation. 60 , 61 Thirdly, the FXR/SHP pathway inhibits PEPCK and G6Pase, thereby suppressing gluconeogenesis and enhancing glucose tolerance and insulin sensitivity. 62 The results suggest that davidiin may modulate the bile acid pool by promoting CYP3A4 expression, leading to a hypoglycemic effect through the FXR-GLP-1/PPAR/SHP pathway.…”
Section: Discussionmentioning
confidence: 99%
“…Based on the assumption that populations from both the Swiss study and our cohort are from a similar ethnic background, we speculate that the major [C] allele of ABCB11 c.1331 T > C might be a high-frequency low-risk contributor towards susceptibility for various complex liver diseases triggered by external stimuli and involving lipid metabolism [ 40 ].…”
Section: Discussionmentioning
confidence: 99%